Traditional Chinese medicine for the treatment of primary dysmenorrhea: How do Yuanhu painkillers effectively treat dysmenorrhea?

Phytomedicine

Volumn 20, Issue 12, 2013, Pages 1095-1104

  Chen, Yuetao ^a,b   Cao, Yu ^a,b   Xie, Yanhua ^a,b   Zhang, Xiaokai ^a,b   Yang, Qian ^a,b   Li, Xiaoqian ^a,b   Sun, Jiyuan ^a,b   Qiu, Pengcheng ^a,b   Cao, Wei ^a,b   Wang, Siwang ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The Cultivation Project of Collaborative Innovation Center for Chinese Medicine in QinBa Mountains   (China)

Author keywords

Ca2+ channel; Imperatorin; NF B; Primary dysmenorrheal; Tetrahydropalmatine; YuanHu painkillers

Indexed keywords

ANALGESIC AGENT; CHINESE DRUG; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; NITRIC OXIDE; OXYTOCIN; PENTOSALEN; SUPEROXIDE DISMUTASE; TETRAHYDROPALMATINE; UNCLASSIFIED DRUG; YUANHU PAINKILLER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DOWN REGULATION; DYSMENORRHEA; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; UTERUS CONTRACTION;

RATTUS; RATTUS NORVEGICUS;

CA(2+) CHANNEL; IMPERATORIN; NF-ΚB; PRIMARY DYSMENORRHEA; TETRAHYDROPALMATINE; YUANHU PAINKILLERS;

ANIMALS; BERBERINE ALKALOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; DYSMENORRHEA; FEMALE; MEDICINE, CHINESE TRADITIONAL; PAIN MANAGEMENT; PREGNANCY; PSORALENS; RATS; RATS, WISTAR;

EID: 84883163473     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.05.003     Document Type: Article

References (53)

1. S. Altunyurt, M. Gol, S. Altunyurt, O. Sezer, and N. Demir Primary dysmenorrhea and uterine blood flow: a color Doppler study Journal of Reproductive Medicine 50 4 2005 251 255
2. K.T. Asokan, S.N. Sarkar, S.K. Mishra, and V. Raviprakash Effects of mibefradil on uterine contractility European Journal of Pharmacology 455 1 2002 65 71
3. C. Bieglmayer, G. Hofer, C. Kainz, A. Reinthaller, B. Kopp, and H. Janisch Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives Gynecological Endocrinology 9 4 1995 307 312
4. T.B. Bolton Mechanisms of action of transmitters and other substances on smooth muscle Physiological Reviews 59 3 1979 606 718
5. I. Buhimschi, C. Yallampalli, Y.L. Dong, and R.E. Garfield Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy American Journal of Obstetrics and Gynecology 172 5 1995 1577 1584
6. C.P. Committee China Pharmacopoeia vol. 1 2010 Chemical Industry Press Beijing 525 526
7. E. Dikensoy, O. Balat, S. Pence, A. Balat, M. Cekmen, and M. Yurekli Malondialdehyde, nitric oxide and adrenomedullin levels in patients with primary dysmenorrhea Journal of Obstetrics and Gynaecology Research 34 6 2008 1049 1053
8. P. D'Ocon, R. Blasco, L. Candenas, D. Ivorra, S. Lopez, C. Villaverde, L. Castedo, and D. Cortes Inhibition of calcium entry induced by cularines and isocrasifoline in uterine smooth muscle European Journal of Pharmacology 196 2 1991 183 187
9. L. French Dysmenorrhea American Family Physician 71 2 2005 285 291
10. T. Godfraind, R. Miller, and M. Wibo Calcium antagonism and calcium entry blockade Pharmacological Reviews 38 4 1986 321 416
11. V. Grgic Dysmenorrhea induced by lumbosacral spine disorders. Pathogenesis, diagnosis and therapy with special emphasis on spinal manipulative therapy Lijecnicki Vjesnik 131 9-10 2009 275 279
12. Z. Gu, M. Kaul, B. Yan, S.J. Kridel, J. Cui, A. Strongin, J.W. Smith, R.C. Liddington, and S.A. Lipton S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death Science 297 5584 2002 1186 1190
13. N.V. Guliaeva, N.L. Luzina, I.P. Levshina, and G.N. Kryzhanovskii The inhibition stage of lipid peroxidation during stress Bulletin of Experimental Biology and Medicine 106 12 1988 660 663
14. S.L. Hendrix, and N.J. Alexander Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive Contraception 66 6 2002 393 399
15. A. Horowitz, C.B. Menice, and K.G. Laporte Mechanisms of smooth muscle contraction Physiological Reviews 76 4 1996 967 1003
16. J.Y. Hu, and G.Z. Jin Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine Zhongguo Yao Li Xue Bao 20 8 1999 715 719
17. L. Hurwitz Pharmacology of calcium channels and smooth muscle Annual Review of Pharmacology and Toxicology 26 1986 225 258
18. N. Ilhan, I. Halifeoglu, H.I. Ozercan, and N. Ilhan Tissue malondialdehyde and adenosine triphosphatase level after experimental liver ischaemia-reperfusion damage Cell Biochemistry and Function 19 3 2001 207 212
19. H. Izumi, C. Yallampalli, and R.E. Garfield Gestational changes in L-arginine-induced relaxation of pregnant rat and human myometrial smooth muscle American Journal of Obstetrics and Gynecology 169 5 1993 1327 1337
20. A.E. Jones Managing the pain of primary and secondary dysmenorrhoea Nursing Times 100 10 2004 40 43
21. J.L. Kang, H.W. Lee, H.J. Kim, H.S. Lee, V. Castranova, C.M. Lim, and Y. Koh Inhibition of SRC tyrosine kinases suppresses activation of nuclear factor-kappaB, and serine and tyrosine phosphorylation of IkappaB-alpha in lipopolysaccharide-stimulated raw 264.7 macrophages Journal of Toxicology and Environmental Health Part A 68 19 2005 1643 1662
22. T. Kawarabayashi, T. Tsukamoto, H. Shojo, S. Nakamura, and H. Sugimori Changes in responsiveness of freshly isolated longitudinal muscle cells from rat uterus towards oxytocin during gestation: contractility and calcium signaling Molecular and Cellular Endocrinology 128 1/2 1997 77 84
23. D.H. Kim, C.H. Kim, M.S. Kim, J.Y. Kim, K.J. Jung, J.H. Chung, W.G. An, J.W. Lee, B.P. Yu, and H.Y. Chung Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde Biogerontology 8 5 2007 545 554
24. S. Kupittayanant, M.J. Luckas, and S. Wray Effect of inhibiting the sarcoplasmic reticulum on spontaneous and oxytocin-induced contractions of human myometrium BJOG 109 3 2002 289 296
25. C.H. Liao, C.T. Ho, and J.K. Lin Effects of garcinol on free radical generation and NO production in embryonic rat cortical neurons and astrocytes Biochemical and Biophysical Research Communications 329 4 2005 1306 1314
26. P. Liu, J.A. Duan, Y.Q. Hua, Y.P. Tang, X. Yao, and S.L. Su Effects of xiang-fu-si-wu decoction and its main components for dysmenorrhea on uterus contraction Journal of Ethnopharmacology 133 2 2011 591 597
27. Z. Lu, W. Sun, X. Duan, Z. Yang, Y. Liu, and P. Tu Chemical constituents from Corydalis yanhusuo Zhongguo Zhong Yao Za Zhi 37 2 2012 235 237
28. J. Marjoribanks, M. Proctor, C. Farquhar, and R.S. Derks Nonsteroidal anti-inflammatory drugs for dysmenorrhoea Cochrane Database of Systematic Reviews 20 1 2010 CD1751
29. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacological Reviews 43 2 1991 109 142
30. L. Myatt, and S.Y. Lye Expression, localization and function of prostaglandin receptors inmyometrium Prostaglandins, Leukotrienes and Essential Fatty acids 70 2 2004 137 148
31. S. Nogawa, C. Forster, F. Zhang, M. Nagayama, M.E. Ross, and C. Iadecola Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia Proceedings of the National Academy of Sciences of the United States of America 95 18 1998 10966 10971
32. Y. Osuga, K. Hayashi, Y. Kobayashi, S. Toyokawa, M. Momoeda, K. Koga, O. Yoshino, O. Tsutsumi, H. Hoshiai, N. Terakawa, and Y. Taketani Dysmenorrhea in Japanese women International Journal of Gynaecology and Obstetrics 88 1 2005 82 83
33. L. Pang, and J.R. Hoult Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages Biochemical Pharmacology 53 4 1997 493 500
34. A.J. Pappano Cholinoceptor-activating and cholinesterase-inhibiting drugs B.G. Katzung, Basic and Clinical Pharmacology 2007 McGraw-Hill Singapore 93 107
35. M. Phillippe, T. Saunders, and A. Basa Intracellular mechanisms underlying prostaglandin F2alpha-stimulated phasic myometrial contractions American Journal of Physiology 273 4 Pt 1 1997 E665 E673
36. V.R. Pickles Prostaglandins and dysmenorrhea. Historical survey Acta Obstetricia et Gynecologica Scandinavica Supplementum 87 1979 7 12
37. M. Proctor, and C. Farquhar Diagnosis and management of dysmenorrhoea BMJ 332 7550 2006 1134 1138
38. Z. Ruttner, T. Ivanics, D.W. Slaaf, R.S. Reneman, A. Toth, and L. Ligeti In vivo monitoring of intracellular free calcium changes during uterine activation by prostaglandin f (2alpha) and oxytocin Journal of the Society for Gynecologic Investigation 9 5 2002 294 298
39. N. Seyhan, and A.G. Canseven In vivo effects of ELF MFs on collagen synthesis, free radical processes, natural antioxidant system, respiratory burst system, immune system activities, and electrolytes in the skin, plasma, spleen, lung, kidney, and brain tissues Electromagnetic Biology and Medicine 25 4 2006 291 305
40. M.F. Sun, H.C. Huang, S.C. Lin, L.P. Chang, and C.F. Liu Evaluation of nitric oxide and homocysteine levels in primary dysmenorrheal women in Taiwan Life Sciences 76 17 2005 2005 2009
41. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park, and S.S. Lee Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mutation Research 480-481 2001 243 268
42. T. Suzer, E. Coskun, S. Demir, and K. Tahta Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine Research in Experimental Medicine 199 4 2000 223 229
43. D.J. Triggle, D.A. Langs, and R.A. Janis Ca-channel ligands structure-function relationships of the 1,4-dihydropyridines Medicinal Research Reviews 9 5 1989 123 180
44. A. Vander, J. Sherman, and D. Laciano Human Physiology: The Mechanism of Body Function 8th ed. 2001 McGraw-Hill Boston 324 332
45. H. Wagner Chromatographic Fingerprint Analysis of Herbal Medicines vol. II 2011 Springer Wien New York p171
46. H. Wagner Chromatographic Fingerprint Analysis of Herbal Medicines vol. I 2011 Springer Wien New York p605
47. Y. Wei, and Y. Ito Preparative isolation of imperatorin, oxypeucedanin and isoimperatorin from traditional Chinese herb "bai zhi"Angelica dahurica (Fisch. ex Hoffm) Benth. et Hook using multidimensional high-speed counter-current chromatography Journal of Chromatography A 1115 1/2 2006 112 117
48. S. Wray, K. Jones, S. Kupittayanant, Y. Li, A. Matthew, E. Monir-Bishty, K. Noble, S.J. Pierce, S. Quenby, and A.V. Shmygol Calcium signaling and uterine contractility Journal of the Society for Gynecologic Investigation 10 5 2003 252 264
49. M.L. Yeh, H.H. Chen, E.C. So, and C.F. Liu A study of serum malondialdehyde and interleukin-6 levels in young women with dysmenorrhea in Taiwan Life Sciences 75 6 2004 669 673
50. H.Y. Yun, V.L. Dawson, and T.M. Dawson Neurobiology of nitric oxide Critical Reviews in Neurobiology 10 3-4 1996 291 316
51. X.K. Zhang, Y.H. Xie, W. Cao, Q. Yang, S. Miao, and S.W. Wang Brain distribution study of imperatorin in rats after oral administration assessed by HPLC Chromatographia 74 3-4 2011 259 265
52. Y. Zhang, H. Xu, X. Chen, C. Chen, H. Wang, F. Meng, H. Yang, and L. Huang Simultaneous quantification of 17 constituents from Yuanhu Zhitong tablet using rapid resolution liquid chromatography coupled with a triple quadrupole electrospray tandem mass spectrometry Journal of Pharmaceutical and Biomedical Analysis 56 3 2011 497 504
53. H.H. Zingg, and S.A. Laporte The oxytocin receptor Trends in Endocrinology and Metabolism 14 5 2003 222 227